Suscribirse

Development and validation of the Exercise-Induced Laryngeal Obstruction Dyspnea Index (EILODI) - 05/04/22

Doi : 10.1016/j.jaci.2021.09.027 
James Tod Olin, MD a, b, , Monica Shaffer, CCC-SLP c, Emily Nauman, CCC-SLP c, Catherine S. Durso, PhD d, Elizabeth M. Fan, PA-C a, Herman Staudenmayer, PhD e, Kent L. Christopher, MD f, Jackie Gartner-Schmidt, CCC-SLP g
a Department of Pediatrics, National Jewish Health, Denver, Colo 
b Department of Medicine, National Jewish Health, Denver, Colo 
c Department of Rehabilitation Medicine, National Jewish Health, Denver, Colo 
d Department of Computer Science, University of Denver, Denver, Colo 
e Department of Psychiatry, University of Colorado School of Medicine, Aurora, Colo 
f Department of Medicine, University of Colorado School of Medicine, Aurora, Colo 
g Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pa 

Corresponding author: James Tod Olin, MD, MSCS, Department of Pediatrics, Division of Pediatric Pulmonology, National Jewish Health, 1400 Jackson St, Denver, CO 80206.Department of PediatricsDivision of Pediatric PulmonologyNational Jewish Health1400 Jackson StDenverCO80206

Abstract

Background

Exercise-induced laryngeal obstruction (EILO) causes exertional dyspnea and is important for its effect on quality of life, diagnostic confusion with exercise-induced asthma, and health care resource utilization. There is no validated patient-reported outcome measure specific to EILO.

Objective

We sought to develop, validate, and define a minimal clinically important difference for a patient-reported outcome measure to be used with adolescents and young adults with EILO.

Methods

A multidisciplinary group created a preliminary measure, modified by a 10-member participant focus group, with 20 items scored along a 5-point Likert scale. A subsequent cohort of participants recruited from a clinic, aged 12 to 21 years, with confirmed EILO by continuous laryngoscopy during exercise testing (1) completed the measure at 3 points in time over 28 days and (2) provided anchoring data in the form of a daily exercise log and categorical self-assessments of clinical improvement. Thirty additional participants without exertional dyspnea served as controls.

Results

Two hundred nineteen subjects with mild to severe EILO participated in the exploratory factor analysis, which identified 7 factors within the preliminary outcome measure. After a process of item reduction, a 12-item metric with a total score ranging from 0 to 48 was developed. Mean scores of patients with EILO and healthy controls at baseline were 28.8 ± 7.4 and 4.5 ± 7.4, respectively. A minimal clinically important difference of 6 was determined by comparison of index change with changes in categorical self-assessments of improvement.

Conclusions

This is the first patient-reported outcome measure specifically designed for adolescents and young adults with EILO.

El texto completo de este artículo está disponible en PDF.

Key words : Exercise-induced laryngeal obstruction, EILO, Exercise-Induced Laryngeal Obstruction Dyspnea Index, EILODI, continuous laryngoscopy during exercise, CLE, vocal cord dysfunction, VCD, paradoxical vocal fold motion, patient-reported outcome measure, questionnaire

Abbreviations used : CLE, EFA, EILO, EILODI, MCID, PROM


Esquema


 This study was not externally funded.
 Disclosure of potential conflict of interest: Outside of institutional affiliation, J. T. Olin is a respiratory consultant for the United States Olympic and Paralympic Committee and USA Swimming and has also received honoraria from speaking at conferences for the American College of Sports Medicine and the Indiana Speech-Language and Hearing Association. The rest of the authors declare that they have no relevant conflicts of interest.


© 2021  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 149 - N° 4

P. 1437-1444 - avril 2022 Regresar al número
Artículo precedente Artículo precedente
  • Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency
  • Maartje Blom, Rolf H. Zetterström, Asbjørg Stray-Pedersen, Kimberly Gilmour, Andrew R. Gennery, Jennifer M. Puck, Mirjam van der Burg
| Artículo siguiente Artículo siguiente
  • ORMDL3 regulates cigarette smoke–induced endoplasmic reticulum stress in airway smooth muscle cells
  • Rui Chen, Charalambos Michaeloudes, Yingmin Liang, Pankaj K. Bhavsar, Kian Fan Chung, Mary S.M. Ip, Judith C.W. Mak

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.